CNTX
Price
$2.31
Change
+$0.01 (+0.43%)
Updated
Feb 5, 02:37 PM (EDT)
Capitalization
211.32M
48 days until earnings call
Intraday BUY SELL Signals
GPCR
Price
$74.58
Change
-$6.68 (-8.22%)
Updated
Feb 5, 03:01 PM (EDT)
Capitalization
5.74B
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CNTX vs GPCR

Header iconCNTX vs GPCR Comparison
Open Charts CNTX vs GPCRBanner chart's image
Context Therapeutics
Price$2.31
Change+$0.01 (+0.43%)
Volume$2.4K
Capitalization211.32M
Structure Therapeutics
Price$74.58
Change-$6.68 (-8.22%)
Volume$200
Capitalization5.74B
CNTX vs GPCR Comparison Chart in %
CNTX
Daily Signal:
Gain/Loss:
GPCR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CNTX vs. GPCR commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTX is a Buy and GPCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (CNTX: $2.30 vs. GPCR: $81.26)
Brand notoriety: CNTX and GPCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTX: 72% vs. GPCR: 59%
Market capitalization -- CNTX: $211.32M vs. GPCR: $5.74B
CNTX [@Biotechnology] is valued at $211.32M. GPCR’s [@Biotechnology] market capitalization is $5.74B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTX’s FA Score shows that 1 FA rating(s) are green whileGPCR’s FA Score has 0 green FA rating(s).

  • CNTX’s FA Score: 1 green, 4 red.
  • GPCR’s FA Score: 0 green, 5 red.
According to our system of comparison, both CNTX and GPCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTX’s TA Score shows that 6 TA indicator(s) are bullish while GPCR’s TA Score has 4 bullish TA indicator(s).

  • CNTX’s TA Score: 6 bullish, 4 bearish.
  • GPCR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CNTX is a better buy in the short-term than GPCR.

Price Growth

CNTX (@Biotechnology) experienced а -4.17% price change this week, while GPCR (@Biotechnology) price change was -8.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.81%. For the same industry, the average monthly price growth was -1.54%, and the average quarterly price growth was +30.06%.

Reported Earning Dates

CNTX is expected to report earnings on Mar 25, 2026.

GPCR is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Biotechnology (-5.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GPCR($5.74B) has a higher market cap than CNTX($211M). CNTX YTD gains are higher at: 56.463 vs. GPCR (16.837). CNTX has higher annual earnings (EBITDA): -30.19M vs. GPCR (-246.42M). GPCR has more cash in the bank: 799M vs. CNTX (76.9M). CNTX has less debt than GPCR: CNTX (140K) vs GPCR (7.09M). CNTX (0) and GPCR (0) have equivalent revenues.
CNTXGPCRCNTX / GPCR
Capitalization211M5.74B4%
EBITDA-30.19M-246.42M12%
Gain YTD56.46316.837335%
P/E RatioN/AN/A-
Revenue00-
Total Cash76.9M799M10%
Total Debt140K7.09M2%
TECHNICAL ANALYSIS
Technical Analysis
CNTXGPCR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
89%
Bullish Trend 4 days ago
87%
Declines
ODDS (%)
Bearish Trend 21 days ago
88%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CNTX
Daily Signal:
Gain/Loss:
GPCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AONNY14.060.21
+1.52%
Aeon Co. Ltd.
HLPPF1.20N/A
+0.17%
Hang Lung Properties Ltd.
ASGOF1.38-0.02
-1.48%
Asante Gold Corp
BSEM5.95-0.55
-8.40%
BioStem Technologies, Inc.
OHCFF0.06-0.01
-10.62%
LIGHT AI INC.

CNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTX has been loosely correlated with RVMD. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTX jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
-6.88%
RVMD - CNTX
54%
Loosely correlated
+0.56%
GPCR - CNTX
54%
Loosely correlated
-3.01%
IMNM - CNTX
53%
Loosely correlated
-2.08%
NRIX - CNTX
53%
Loosely correlated
-1.43%
INBX - CNTX
52%
Loosely correlated
-2.96%
More

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been closely correlated with ATOS. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if GPCR jumps, then ATOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
-3.01%
ATOS - GPCR
80%
Closely correlated
-4.34%
PHGE - GPCR
77%
Closely correlated
-7.36%
PMN - GPCR
77%
Closely correlated
-1.57%
CANF - GPCR
74%
Closely correlated
-0.25%
ANL - GPCR
73%
Closely correlated
+7.23%
More